These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 8744821)
21. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times. Kim JH; Kim MJ; Suh SH; Chung JJ; Yoo HS; Lee JT J Magn Reson Imaging; 2002 May; 15(5):573-83. PubMed ID: 11997899 [TBL] [Abstract][Full Text] [Related]
22. Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T. Whitney WS; Herfkens RJ; Jeffrey RB; McDonnell CH; Li KC; Van Dalsem WJ; Low RN; Francis IR; Dabatin JF; Glazer GM Radiology; 1993 Dec; 189(3):863-70. PubMed ID: 8234717 [TBL] [Abstract][Full Text] [Related]
23. Optimal MR protocol for hepatic hemangiomas. Comparison of conventional spin-echo sequences with T2-weighted turbo spin-echo and serial gradient-echo (FLASH) sequences with gadolinium enhancement. Kim TK; Choi BI; Han JK; Jang HJ; Han MC Acta Radiol; 1997 Jul; 38(4 Pt 1):565-71. PubMed ID: 9240679 [TBL] [Abstract][Full Text] [Related]
24. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Grazioli L; Morana G; Kirchin MA; Schneider G Radiology; 2005 Jul; 236(1):166-77. PubMed ID: 15955857 [TBL] [Abstract][Full Text] [Related]
25. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330 [TBL] [Abstract][Full Text] [Related]
33. Small hepatocellular carcinoma: differentiation from adenomatous hyperplasia with color Doppler US and dynamic Gd-DTPA-enhanced MR imaging. Lencioni R; Mascalchi M; Caramella D; Bartolozzi C Abdom Imaging; 1996; 21(1):41-8. PubMed ID: 8672971 [TBL] [Abstract][Full Text] [Related]
34. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging. Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572 [TBL] [Abstract][Full Text] [Related]
35. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media]. Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882 [TBL] [Abstract][Full Text] [Related]
36. Gadobenate dimeglumine-enhanced liver magnetic resonance imaging: value of hepatobiliary phase for the detection of focal liver lesions. Fu GL; Du Y; Zee CS; Yang HF; Li Y; Duan RG; Zeng NL; Xiao DM J Comput Assist Tomogr; 2012; 36(1):14-9. PubMed ID: 22261765 [TBL] [Abstract][Full Text] [Related]
37. Non-breath-hold fast spin-echo versus breath-hold fast spin-echo and spoiled gradient-recalled echo MR imaging in the detection of hepatic tumors: correlation with surgical findings. Soyer P; Gouhiri M; Rondeau Y; Spelle L; Mosnier H; Scherrer A AJR Am J Roentgenol; 1997 May; 168(5):1199-204. PubMed ID: 9129411 [TBL] [Abstract][Full Text] [Related]
38. Characterization of hepatocellular tumors: value of mangafodipir-enhanced magnetic resonance imaging. Scharitzer M; Schima W; Schober E; Reimer P; Helmberger TK; Holzknecht N; Stadler A; Ba-Ssalamah A; Weber M; Wrba F J Comput Assist Tomogr; 2005; 29(2):181-90. PubMed ID: 15772534 [TBL] [Abstract][Full Text] [Related]
39. Gadoteridol-enhanced MR imaging of malignant hepatic tumors: effects of triple versus standard doses on lesion-liver contrast. Petersein J; Saini S; Mitchell DG; Davis PL; Johnson CD; Kuhlman JE; Parisky YR; Runge VM; Weinreb J; Bernardino ME AJR Am J Roentgenol; 1995 Nov; 165(5):1157-61. PubMed ID: 7572495 [TBL] [Abstract][Full Text] [Related]
40. Detection of focal hepatic lesions with MR imaging: prospective comparison of T2-weighted fast spin-echo with and without fat suppression, T2-weighted breath-hold fast spin-echo, and gadolinium chelate-enhanced 3D gradient-recalled imaging. Soyer P; de Givry SC; Gueye C; Lenormand S; Somveille E; Scherrer A AJR Am J Roentgenol; 1996 May; 166(5):1115-21. PubMed ID: 8615254 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]